NCT02710409View on ClinicalTrials.gov

A Phase III Clinical Trial of An Inactivated Quadrivalent Influenza Vaccine in Healthy Subjects Aged 3 Years and Older

PHASE3CompletedINTERVENTIONAL
Enrollment

3,664

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

June 30, 2016

Study Completion Date

August 31, 2016

Conditions
Influenza
Interventions
BIOLOGICAL

Quadrivalent influenza vaccine

0.5 ml/vial, one dose, intramuscular injection on day 0

BIOLOGICAL

Trivalent influenza vaccine A

0.5 ml/vial, one dose, intramuscular injection on day 0

BIOLOGICAL

Trivalent influenza vaccine B

0.5 ml/vial, one dose, intramuscular injection on day 0

Trial Locations (1)

Unknown

Guanyun County Center for Disease Control and Prevention, Lianyungang

All Listed Sponsors
collaborator

Jiangsu Jindike Biotechnology Co., Ltd.

INDUSTRY

lead

Jiangsu Province Centers for Disease Control and Prevention

NETWORK

NCT02710409 - A Phase III Clinical Trial of An Inactivated Quadrivalent Influenza Vaccine in Healthy Subjects Aged 3 Years and Older | Biotech Hunter | Biotech Hunter